Contact Information
  • 800-826-HOPE (4673)
Saro Armenian, D.O., M.P.H.
  • Associate Professor
  • Director, Childhood Cancer Survivorship Clinic
  • Interim Director, Division of Outcomes Research, Department of Population Sciences

Languages Spoken
  • English
  • Armenian
  • French
  • Arabic

Biography

Dr. Armenian is a pediatric oncologist with expertise in pediatric cancer, epidemiology, and cancer survivorship. He is an associate professor in the Departments of Pediatrics and Population Sciences, and serves as the Director of the Childhood Cancer Survivorship Program at City of Hope. His research is focused on understanding the pathophysiology and risk factors for cardiovascular complications such as therapy-related heart failure, coronary artery disease, and stroke in long-term survivors of cancer. Taken together, these complications are a leading cause of mortality in survivors of cancer and pose one of the greatest challenges to clinicians taking care of these patients. As chair of the Children’s Oncology Group Survivorship and Outcomes Committee, Dr. Armenian plays a lead role in shaping national guidelines for the care of childhood cancer survivors. He has been the recipient of several awards including the American Society of Bone Marrow Transplantation HistoGenetics New Investigator Award, Paul Calebresi Clinical Oncology Career Development Award, the Ruby N. Roney Endowment at City of Hope, and is a past-fellow of the American Society of Hematology Clinical Training Institute.

Professional Experience

  • 2014 to present, Associate Professor, Division of Outcomes Research, Department of Population Sciences, City of Hope, Duarte, CA
  • 2008 - 2014, Assistant Professor and Medical Director, Childhood Cancer Survivorship Program, Department of Population Sciences, City of Hope, Duarte, CA

Education

Education/Training
  • 2005 - 2008, Fellowship, Division of Hematology-Oncology, Childrens Hospital Los Angeles, University of Southern California, Los Angeles
  • 2006 - 2007, Department of Preventive Medicine, University of Southern California, Los Angeles, M.P.H., Epidemiology/Biostatistics
  • 2003 - 2005, Residency, Department of Pediatrics, Childrens Hospital Los Angeles, University of Southern California, Los Angeles
  • 1998 - 2002, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA, D.O.
  • 1992 - 1996, University of Chicago, IL, B.A., Psychology
 

Honors/Awards

Awards
  • 2012, Ruby N. Roney Endowment for Outstanding Faculty in Cancer Survivorship, City of Hope
  • 2011, National Marrow Donor Program Award, Best Abstract, American Society of Hematology Annual Meeting
  • 2011, Research Career Development Award, STOP CANCER Foundation
  • 2010, Paul Calebresi Clinical Oncology Career Development Award, City of Hope
  • 2010, HistoGenetics New Investigator Award, American Society of Bone Marrow Transplantation
  • 2009 & 2010, Faculty Instructor of the Year, Clinical Investigation Training Program, City of Hope
  • 2006, Fellow Teacher of the Year, for outstanding teaching and commitment, Childrens Hospital Los Angeles
  • 2005, Della M. Mudd Award for effective application of scientific knowledge, perceptiveness in the care of children and distinguished qualities of character, Childrens Hospital Los Angeles
  • 2003, Frances Nunnally Winzer Scholar for outstanding medical service as a pediatric intern, Childrens Hospital Los Angeles
  • 2002, Charles Vowels M.D. Award for academic excellence and for exhibiting the qualities of concerned patient care, and dedication to clinical teaching, Western University of Health Sciences
  • 2002, Department of Pediatrics Annual Award for excellence in the field of pediatric medicine, Western University of Health Sciences

Honors
  • 2007 - 2008, Fellow, Clinical Research Training Institute, American Society of Hematology
  • 1996, Psi Chi National Honors Society, University of Chicago
 

Memberships

2015 – present, Member, Medical Executive Committee, City of Hope
2014 – present, Co-Chair, American Society of Clinical Oncology, Cardiovascular Disease Screening Expert Panel
2014 – present, Member, Editorial Review Board, Cancer
2013 – present, Member, Grant Review Committee, Curesearch Foundation
2013 – present, Member, Medical Advisory Board, Rally Foundation
2013 – present, Member, Scientific Advisory Board,  Ryan’s Light Foundation
2013 – present, Member, Faculty Philanthropy Committee, City of Hope
2012 – present, Co-Chair, International Late Effects of Childhood Cancer Guideline Harmonization Group: Cardiomyopathy Screening Committee
2011 – present, Member, International Late Effects of Childhood Cancer Guideline Harmonization Group: Development Core Committee
2010 – present, Member, Scientific Advisory Board, Pablove Foundation
2010 – present, Chair, Survivorship and Outcomes Committee, Children’s Oncology Group
2009 – 2014, Chair, Cardiovascular-Pulmonary Late Effects Taskforce, Children’s Oncology Group

Locations

  • City of Hope - Main Campus (Duarte)
    1500 East Duarte Road
    Duarte, CA 91010

Publications

Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan P, Shankar S, Sieswerda E, Skinner R, Steinberger J, van Dalen E, van der Pal H, Wallace H, Levitt G, Kremer LC. Recommendations for Cardiomyopathy Surveillance for Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. In Press, Lancet Oncology.
 
Bhatia S, Armenian SH, Armstrong GT, van Dulmen-Den Broeder E, Hawkins M, Kremer LCM, Kuehni CE, Olsen JH, Robison LL, Hudson MM. Cancer Survivorship – the current landscape. In Press, J Clin Oncol.
 
Armenian SH, Landier L, Francisco L, Herrera C, Mills G, Siyahian A, Supab N, Wilson K, Wolfson J, Horak D, Bhatia S. Long-term pulmonary function in survivors of childhood cancer. In Press, J Clin Oncol.
 
Landier W, Armenian SH, Bhatia S. Late effects of childhood cancer and its treatment. Pediatr Clin N Am. 2015 Feb;62(1):275-300.
 
Armenian SH. Improving screening practices in childhood cancer survivors at risk for treatment-related heart failure. J Clin Oncol. 2014 Dec 10;32(35):3923-5.
 
Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res. 2014 Dec 15;20(24):6314-23.
 
Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1109-14.
 
Wong FL, Bhatia S, Kurian S, Landier W, Francisco L, Leisenring W, Hudson M, Armstrong GT, Mertens A, Stovall M, Yasui Y, Robison LL, Lipshultz SE, Armenian SH. Evaluation of the effectiveness of the Children’s Oncology Group (COG) Long-term Follow-up Guidelines in reducing the risk of anthracycline-related congestive heart failure (CHF) in long-term survivors of childhood cancer. Ann Intern Med. 2014; May 20; 160:672-83.
 
Wang X, Liu W, Sun CL, Armenian SH, Hageman L, Ding Y, Landier W, Blanco JG, Winick N, Ginsberg J, Keller F, Neglia JP, Grundy P, Oeffinger KC, McLean T, Cherrick I, Bomgaars L, Yasui Y, Relling MV, Bhatia S. Hyaluronidase synthase 3 (HAS3) variant and anthracycline-related cardiomyopathy – a report from the Children’s Oncology Group. J Clin Oncol. 2014 Mar 1; 32(7):647-53.

Armenian SH, Chow EJ. Cardiovascular disease in survivors of hematopoietic cell transplantation.  Cancer. 2014 Feb 15; 120(4):469-79.
 
Armenian SH, Ding Y, Mills G, Sun CL, Venkatraman K, Wong FL, Senitzer D, Wang S, Forman SJ, Bhatia S. Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure in Survivors of Hematopoietic Cell Transplantation. Br J Haematol. 2013 Oct; 163(2):205-13.
 
Sun CL, Kersey JH, Armenian SH, Baker KS, Weisdorf DJ, Forman S, Bhatia S. Burden of morbidity 10+ years after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Biol Blood Marrow Transplant. 2013 Jul; 19(7):1073-80.
 
Mascarenhas L, Malogolowkin M, Armenian SH, Sposto R, Venkatramani R. A phase I study of oxaliplatin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul; 60(7):1103-7.
 
Armenian SH, Landier W, Hudson MM, Robison LL, Bhatia S. Children’s Oncology Group’s 2013 Blueprint for Research: Survivorship and Outcomes. Pediatr Blood Cancer. 2013 Jun; 60(6):1063-8.
 
Kremer LCM, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, Caron HN, Armenian SH, Skinner R, Hudson MM. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013 Apr; 60(4):543-9.
 
VanderWalde AM, Sun CL, Laddaran L, Francisco L, Armenian S, Berano-Teh J, Wong FL, Popplewell L, Somlo G, Stein A, Nademanee A, Krishnan A, Kogut N, Forman SJ, Bhatia S. Conditional Survival after Autologous Hematopoietic Cell Transplantation. Leukemia. 2013 Apr; 27(5):1139-45.
 
Armenian SH, Robison LL. Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects. Curr Opin Pediatr. 2013 Feb; 25(1):16-22.
 
Armenian SH. Risk factors of cardiovascular disease after hematopoietic cell transplantation. Clin Adv Hematol Oncol. 2013. Feb; 11(2):1-2.
 
Landier W, Armenian SH, Lee J, Thomas O, Wong FL, Francisco L, Herrera C, Kasper C, Wilson K, Zomorodi M, Bhatia S. Yield and Utility of Screening for Late-Effects using the Children’s Oncology Group Long-Term Follow-Up (COG-LTFU) Guidelines. J Clin Oncol. 2012 Dec 10; 30(35):4401-8.
 
Armenian SH, Sun CL, Shannon T, Ness K, Blum E, Francisco L, Venkataraman K, Samoa R, Wong FL, Forman SJ, Bhatia S. Cardiovascular risk factors in hematopoietic cell transplantation (HCT) survivors: role in development of subsequent cardiovascular disease. Blood. 2012 Nov 29; 120(23):4505-12.
 
Armenian SH, Gelehrter SK, Chow EJ. Strategies to Prevent Anthracycline-related Congestive Heart Failure (CHF) in Survivors of Childhood Cancer. Cardiol Res Pract. 2012; 2012:713294.
 
Pulsipher MA, Skinner R, McDonald G, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryck A, Bhatia S, Bunin N, Nieder ML, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Baker KS. NCI, NHLBI/PBMTC First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Guidelines for Follow Up. Biol Blood Marrow Transplant. 2012 Mar; 18(3):334-47.
 
Armenian SH, Sun CL, Francisco L, Arora M, Baker KS, Forman SJ, Bhatia S. Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Bone Marrow Transplant. 2012 Feb; 47(2):283-90.
 
Armenian SH, Sun CL, Mills G, Shannon T, Francisco L, Venkataraman K, Wong FL, Forman SJ, Bhatia S. Incidence and predictors of congestive heart failure (CHF) after hematologic malignancies treated with autologous hematopoietic cell transplantation (aHCT). Blood. 2011 Dec 1; 118(23):6023-9.
 
Nieder ML, McDonald G, Hingorani S, Armenian SH, Cooke KR, Pulsipher MA, Baker KS. NCI, NHLBI/PBMTC First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: long term organ damage and dysfunction following pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1573-84.
 
Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, Baker KS, Francisco L, The JB, Mills G, Wong FL, Rosenthal J, Diller L, Hudson MM, Oeffinger KC, Forman SJ, Robison LL, Bhatia S. Long-term outcomes in survivors of childhood cancer treated with hematopoietic cell transplantation (HCT) versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011 Aug 4; 118(5):1413-20.
 
Ness KK, Armenian SH, Kadan-Lottick N, Gurney J. Adverse effects of treatment in childhood acute lymphoblastic leukemia: implications for long-term cardiac health. Exp Rev Hematol. 2011 Apr; 4(2):185-97.
 
Armenian SH, Sun CL, Berano Teh J, Arora M, Baker KS, Francisco L, Forman SJ, Bhatia S. Ethnic Differences in Chronic Health Conditions after Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor Study. Cancer. 2010 Sep 1; 116(17):4152-9. NIHMSID: NIHMS189758.
 
Armenian SH, Sun CL, Mills G, Berano Teh J, Francisco L, Durand JB, Wong FL, Forman SJ, Bhatia S. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010 Aug; 16(8):1138-1144. PMCID: PMC2888883.
 
Baker KS, Armenian S, Bhatia S. Long Term Consequences Of Hematopoietic Stem-Cell Transplantation: Current State Of The Science. Biol Blood Marrow Transplant. 2010 Jan; 16(1 Suppl):S90-6. PMCID: PMC2832710.
 
Armenian SH, Nash KA, Kapoor N, Franklin J, Gaynon PS, Ross LA, Hoffman JA.  Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J Pediatr Hematol Oncol. 2009 Dec; 31(12):920-6.
 
Armenian SH, Bhatia S. Chronic health conditions in childhood cancer survivors: is it all treatment related – or do genetics play a role? J Gen Intern Med. 2009 Nov; 24 Suppl 2:S395-400. PMCID: PMC2763170.
 
Armenian SH, Sun CL, Francisco L, Steinberger J, Kurian S, Wong L, Sharp J, Sposto R, Forman SJ, Bhatia S.  Late congestive heart failure (CHF) following hematopoietic cell transplantation (HCT). J Clin Oncol. 2008 Dec 1; 26(34):5537-43. PMCID: PMC2651101.
 
Armenian SH, Bhatia S.  Cardiovascular disease after Hematopoietic Cell Transplantation – lessons learned.  Haematologica. 2008 Aug; 93(8):1132-6.
 
Armenian SH, Panigrahy A, Murphree AL, Jubran RF.  Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Pediatr Blood Cancer. 2008 Oct; 51(4):479-84.
 
Armenian SH, Hoffman JA, Butturini A, Kapoor N, Mascarenhas L.  Invasive diagnostic procedures for pulmonary infiltrates in pediatric Hematopoietic Stem Cell Transplant recipients. Pediatr Transplant.  2007 Nov; 11(7): 736-42.
 
Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L.  Extra-Cranial Malignant Rhabdoid Tumors in Childhood: The Childrens Hospital Los Angeles Experience. Cancer. 2007 Nov 1; 110(9): 2061-6.
 
Sano H, Gonzalez-Gomez I, Wu SQ, Armenian SH, Jubran RF, Shimada H.  A case of composite neuroblastoma composed of histologically and biologically distinct clones. Pediatr Dev Pathol. 2007 May-Jun; 10(3): 229-32.
 
Armenian SH, La Via WV, Siegel SE, Mascarenhas L. Evaluation of persistent pulmonary infiltrates in pediatric oncology patients.  Pediatr Blood Cancer. 2007 Feb; 48(2): 165-72.
 
Armenian SH, Han JY, Dunaway TM, Chruch JA.  Safety and immunogenicity of live varicella virus vaccine in children with Human Immunodeficiency Virus type 1. Pediatr Infect Dis J. 2006 Apr; 25(4): 368-370.
 
Armenian SH, Singh J Arrieta AC.  Risk factors for mortality resulting from bloodstream infections in a Pediatric Intensive Care Unit.  Pediatr Infect Dis J. 2005 Apr; 24: 309-314.
 
Armenian S, Yang F.  Evaluation of persistent neutropenia in a one-month old female with repeated pyogenic infections. Journal of Southern California Clinicians. 2005; 2(1): 11-15.
 
Armenian S, Raffel J, Nugent D, Young G.  Painless urethral bleeding: an unusual presentation of von Willebrand disease. Haemophilia. 2003 May; 9(3): 332-5.
 
Armenian SH, Chutuape MA, Stitzer ML.  Predictors of discharges against medical advice from a short term hospital detoxification unit. Drug and Alcohol Dependence. 1999 Aug 2; 56(1): 1-8.